Acorda Therapeutics
ACOR
#11225
Rank
NZ$1.45 M
Marketcap
NZ$1.17
Share price
0.00%
Change (1 day)
-95.49%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -NZ$0.44 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are NZ$0.11 Billion. In 2023 the company made an earning of -NZ$0.47 Billion a decrease over its 2022 earnings that were of -NZ$9.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.44 Billion-7.88%
2023 -NZ$0.47 Billion4848.63%
2022 -NZ$9.48 Million-93.25%
2021 -NZ$0.15 Billion2.52%
2020 -NZ$0.14 Billion-69.45%
2019 -NZ$0.45 Billion-700.62%
2018 NZ$74.57 M-118.02%
2017 -NZ$0.42 Billion805.99%
2016 -NZ$45.69 Million-173.88%
2015 NZ$61.83 M-6.58%
2014 NZ$66.18 M20.19%
2013 NZ$55.07 M18.7%
2012 NZ$46.39 M-26.54%
2011 NZ$63.15 M
2009 -NZ$0.15 Billion10.65%
2008 -NZ$0.14 Billion86.17%
2007 -NZ$70.01 Million68.1%
2006 -NZ$41.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-NZ$0.24 Billion-51.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.13 B-127.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-NZ$0.14 Billion-71.86%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
NZ$0.26 B-154.87%๐Ÿ‡บ๐Ÿ‡ธ USA